PCVX ▲ +7.9% - Vaxcyte, Inc.
$PCVX reported Q3 2026 EPS of -$1.99, beating the -$2.06 estimate by 3.4%. Revenue was $0. No analyst estimate was published for revenue.
04-NOV-2026 04:35 PM ET
Share this post
More filings for $PCVX
PCVX ▲ +7.9% - Vaxcyte, Inc.Nov 4, 2026PCVX ▲ +9.4% - Vaxcyte, Inc.Oct 10, 2026PCVX ▼ -0.9% - Vaxcyte, Inc.Oct 7, 2026PCVX ▼ -9.8% - Vaxcyte, Inc.Oct 7, 2026PCVX ▲ +27.3% - Vaxcyte, Inc.Oct 5, 2026PCVX ▲ +10.4% - Vaxcyte, Inc.Oct 5, 2026
View full $PCVX filing history →💬 Comments
Loading comments…
Leave a comment